Effect of eculizumab on haemolysis‐associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria by Hill, Anita, Rother, Russell P., Wang, Xunde, Morris, Jr, Sidney M., Quinn‐Senger, Kerry, Kelly, Richard, Richards, Stephen J., Bessler, Monica, Bell, Leonard, Hillmen, Peter, Gladwin, Mark T.

Get full text

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria by Schubert, Jörg, Hillmen, Peter, Röth, Alexander, Young, Neal S., Elebute, Modupe O., Szer, Jeffrey, Gianfaldoni, Giacomo, Socié, Gérard, Browne, Paul, Geller, Robert, Rother, Russell P., Muus, Petra

Get full text

Staking out novelty on the genomic frontier by Quinn-Senger, Kerry E, Ramachandran, Ravi, Rininger, Joseph A, Kelly, Karen M, Lewin, David A

Get full text

Eculizumab Reduces Pulmonary Hypertension through Inhibition of Hemolysis-Associated Nitric Oxide Consumption in Patients with Paroxysmal Nocturnal Hemoglobinuria by Hill, Anita, Rother, Russell P., Wang, Xunde, Sapsford, Robert J, Collinson, Paul O, Gaze, David C, Morris, Sidney M, Scally, Andrew, Quinn-Senger, Kerry, Richards, Stephen J, Bessler, Monica, Kelly, Richard, Hillmen, Peter, Gladwin, Mark

Get full text

Effect of the Terminal Complement Inhibitor Eculizumab on Patient Reported Outcomes in Paroxysmal Nocturnal Hemoglobinuria (PNH): Phase III Triumph Study Results by Brodsky, Robert A., Muus, Petra, Dührsen, Ulrich, Hill, Anita, Bessler, Monica, Coutre, Steven, De Paz, Raquel, Moskovits, Tibor, Nakamura, Ryotaro, Van den Neste, Eric, Zanella, Alberto, Quinn-Senger, Kerry, Kroon, Henk-Andre, Cella, David

Get full text